STOCK TITAN

Willis Towers Watson Public Limited Company Form 4 Filings

WTW NASDAQ

Every Form 4 that Willis Towers Watson Public Limited Company (WTW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow WTW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WTW filings page.

Rhea-AI Summary

At Willis Towers Watson plc, President of Risk & Broking Lucy Clarke had 1,916 ordinary shares withheld by the issuer on October 1, 2026, for tax liability related to vesting and settlement of restricted share units granted October 1, 2024. She reported direct ownership of 20,841 ordinary shares following the transaction.

Rhea-AI Summary

Krasner Andrew Jay reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson plc reported that Chief Financial Officer Andrew Jay Krasner received a grant of 4.2095 restricted share units tied to ordinary shares. These units were credited under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and increase his total plan-related restricted share units to 758.3733. Each unit is designed to settle into one ordinary share with a nominal value of $0.000304635 per share upon specified distribution events.

Rhea-AI Summary

WILLIS TOWERS WATSON PLC reported that Chief Executive Officer Carl Aaron Hess acquired 53.426 restricted share units linked to its Ordinary Shares. The units were credited under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and reflect the Plan’s accrual formula, net of the participant’s own contributions. Following this award, Hess directly holds 8,512.1156 restricted share units tied to Ordinary Shares. These units settle into Ordinary Shares on a 1:1 basis under the Plan’s deferred settlement terms.

Rhea-AI Summary

Gebauer Julie Jarecke reported acquisition or exercise transactions in this Form 4 filing.

WILLIS TOWERS WATSON PLC executive Julie Jarecke Gebauer, Pres.-Health, Wealth & Career, reported an award of 12.6282 restricted share units under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees. These units settle into Ordinary Shares on a 1:1 basis upon specified separation or death-related distribution events, bringing her total plan-related restricted share units to 5,626.3389.

Rhea-AI Summary

Willis Towers Watson PLC Chief Operating Officer Alexis Faber reported an open-market sale of 730 Ordinary Shares on August 10, 2026 at $342.7010 per share. After this transaction, Faber directly holds 10,751.542 Ordinary Shares and has an additional 1 share held indirectly by an immediate family member.

Rhea-AI Summary

Willis Towers Watson PLC Chief Financial Officer Andrew Jay Krasner reported small equity awards linked to company benefit plans. On July 15, 2026 he acquired 15.003 dividend-equivalent ordinary shares, bringing his direct holdings to 4,475.127 shares, alongside 19,599.0864 ordinary shares held indirectly through a revocable trust.

He was also credited with 8.6361 restricted share units under the Non-Qualified Deferred Savings Plan and 2.5214 units under the Non-Qualified Stable Value Excess Plan, each settling into ordinary shares on a 1:1 basis under the plans’ specified post-employment payout schedules.

Rhea-AI Summary

Imran Ahmed Qureshi, Global Head of Geographies at Willis Towers Watson PLC, reported receiving small equity-based awards on July 15, 2026. He acquired 6.354 ordinary shares as dividend equivalent rights on prior restricted share units, bringing his direct holdings to 2,359.010 ordinary shares. He was also credited 10.3745 and 5.6843 restricted share units as dividend and matching contributions under non-qualified employee plans, each convertible into one ordinary share on deferred settlement schedules. He additionally reports indirect ownership of 9,860.871 ordinary shares through a revocable trust.

Rhea-AI Summary

Willis Towers Watson Co-Head of Corporate Dev. Anne Pullum reported compensation-related acquisitions on July 15, 2026. She received 6.6310 Ordinary Shares as dividend-equivalent rights, increasing her direct holdings to 22,448.2439 shares, plus 8.6480 and 3.1008 restricted share units credited as dividends under two non-qualified employee plans that settle 1:1 into Ordinary Shares upon future separation events.

Rhea-AI Summary

Willis Towers Watson PAO and Controller Joseph Stephen Kurpis reported small equity-based awards. On July 15, 2026 he acquired 0.6140 ordinary shares through dividend equivalent rights tied to earlier RSU awards, plus 1.3844 and 1.5099 restricted share units credited under two non-qualified employee plans. These RSUs settle 1:1 into ordinary shares on future separation-based dates set by each plan. Following these awards he directly holds 1,693.0300 ordinary shares, 421.1378 RSUs under the Non-Qualified Deferred Savings Plan and 449.9350 RSUs under the Non-Qualified Stable Value Excess Plan.

Rhea-AI Summary

Willis Towers Watson chief executive Carl Aaron Hess reported equity awards tied to company plans on 2026-07-15. He acquired 51.9050 ordinary shares through dividend equivalent rights on previously reported restricted share units and received new restricted share units representing 28.3525 and 35.1458 underlying ordinary shares credited under non-qualified deferred compensation plans, bringing his directly held position to 117547.8266 ordinary shares and plan-based restricted share unit balances of 8458.6896 and 10557.2873 units.

Rhea-AI Summary

Willis Towers Watson reports that Pres.-Health, Wealth & Career Julie Jarecke Gebauer received equity-based awards. She acquired 11.6690 ordinary shares as dividend-equivalent rights on existing restricted share units and 82.2257 and 18.8305 restricted share units credited as dividends under two non-qualified employee plans. Following these awards, she holds 78,033.9245 ordinary shares directly, plus 534.0000 shares held indirectly in each of two family management trusts.

Rhea-AI Summary

Willis Towers Watson plc General Counsel Matthew Furman reported acquisitions of share-based awards tied to dividends and deferred compensation. He received 6.0770 Ordinary Shares through dividend equivalent rights on previously reported restricted share unit awards, which vest on the same schedule as the underlying awards.

He was also credited with 12.1846 Restricted Share Units under the Non-Qualified Deferred Savings Plan and 8.7424 Restricted Share Units under the Non-Qualified Stable Value Excess Plan. These RSUs are credited based on deferral elections, company matching contributions, and related dividends, and each unit will settle into one Ordinary Share under the applicable post-termination or separation schedules. Following these transactions, he directly holds 35,561.3529 Ordinary Shares, 3,682.5396 RSUs under the savings plan, and 2,605.2072 RSUs under the excess plan.

Rhea-AI Summary

Willis Towers Watson plc reported that Chief Operating Officer Alexis Faber acquired additional equity interests on 15 July 2026. Awards included 5.695 dividend-equivalent ordinary share rights tied to prior restricted share units and new RSU credits from dividends under two non-qualified U.S. employee plans. Following these transactions, Faber holds 11,481.542 ordinary shares directly, plan-based RSUs, and 1 ordinary share indirectly through an immediate family member.

Rhea-AI Summary

Willis Towers Watson plc reports that Lucy Clarke, President of Risk & Broking, acquired 41.075 dividend equivalent rights linked to ordinary shares on July 15, 2026. These rights accrued on previously reported restricted share unit awards and vest on the same schedule. Each right is the economic equivalent of one WTW ordinary share, bringing her direct holdings to 22,758.528 ordinary shares.

Rhea-AI Summary

Willis Towers Watson PLC executive Kristy D. Banas, Chief Human Resources Officer, reported compensation-related acquisitions on July 15, 2026. She was credited with 5.1740 dividend equivalent rights economically equivalent to Ordinary Shares, and additional restricted share units of 1.8667 and 4.3451 tied to non-qualified employee plans and dividend accruals. Following these transactions, she directly holds 11,365.7038 Ordinary Shares and 556.2179 and 1,338.1591 restricted share units in the respective plans.

Rhea-AI Summary

Willis Towers Watson PLC reports that Chief Human Resources Officer Kristy D. Banas received a grant of 43.3100 restricted share units on 2026-07-10, each linked 1:1 to ordinary shares. These units settle in shares six months after her termination date. Following this award, she directly holds 1333.8140 restricted share units, which include units acquired under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees.

Rhea-AI Summary

Faber Alexis reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson plc Chief Operating Officer Alexis Faber received a grant of 47.6515 restricted share units on 2026-07-10 at a reported transaction price of $289.6500 per unit. Following this award, she directly holds 2596.2798 restricted share units. The units settle into ordinary shares on a 1:1 basis six months after her termination date and include amounts credited under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees.

Rhea-AI Summary

Furman Matthew reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson PLC granted General Counsel Matthew Furman 51.5389 restricted share units linked to ordinary shares, with a transaction price of $289.6500 per unit. After this award, he directly holds 3670.3552 restricted share units, which settle into ordinary shares on a 1:1 basis six months after his termination date. These holdings include units credited under the company’s Non-Qualified Deferred Savings Plan for U.S. employees through deferrals and matching contributions.

Rhea-AI Summary

Gebauer Julie Jarecke reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson plc reported that executive Julie Jarecke Gebauer, Pres.-Health, Wealth & Career, received two awards of restricted share units on 2026-07-10 for 2.2402 and 65.4026 units at a reference price of $289.65 per unit. These compensation-related RSUs, credited under non-qualified deferred compensation plans, settle into ordinary shares on a 1:1 basis after separation from service, leaving plan balances of 5,594.8804 and 24,486.4233 units, respectively.

Rhea-AI Summary

Pullum Anne reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson plc reports that Co-Head of Corporate Development Anne Pullum received a grant of 51.8 restricted share units on July 10, 2026, at a reported value of $289.65 per underlying ordinary share. This award brings her directly held restricted share units to 2,620.2843. The units settle into ordinary shares on a 1:1 basis six months after her termination date and include amounts credited under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees through her deferral elections and related company matching contributions.

Rhea-AI Summary

Kurpis Joseph Stephen reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson PLC reported an equity award for PAO and Controller Joseph Stephen Kurpis. He received 8.5779 restricted share units on 2026-07-10, valued at $289.6500 per underlying ordinary share, increasing his deferred RSU holdings to 419.7534 units that settle into ordinary shares 6 months after termination.

Rhea-AI Summary

Qureshi Imran Ahmed reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson PLC reported that Imran Ahmed Qureshi, Global Head of Geographies, received a grant of 51.7992 restricted share units, valued at $289.65 per unit, linked 1:1 to Ordinary Shares with nominal value $0.000304635 per share.

Following this award, Qureshi holds a total of 3,133.0402 restricted share units directly. The units generally settle in Ordinary Shares on a 1:1 basis six months after the reporting person’s termination date and include units credited under the Willis Towers Watson Non-Qualified Deferred Savings Plan through deferral elections and company matching contributions.

Rhea-AI Summary

Krasner Andrew Jay reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson PLC reported that Chief Financial Officer Andrew Jay Krasner received two restricted share unit (RSU) awards on July 10, 2026. The grants cover 2.7632 and 66.8242 RSUs, each tied to ordinary shares at a reference price of $289.65 per unit. Following the awards, he holds 751.6421 and 2,631.7548 RSUs in these award lines, which settle into ordinary shares on a 1:1 basis under the company’s non-qualified deferred compensation plans, generally after separation from service or other specified events.

Rhea-AI Summary

Hess Carl Aaron reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson plc reported that Chief Executive Officer Carl Aaron Hess received two awards of restricted share units (RSUs) on 2026-07-10. The grants covered 9.6986 and 83.8109 RSUs, each referenced at $289.65 per unit, tied to ordinary shares with a nominal value of $0.000304635. After these awards, reported RSU holdings under the relevant plans rose to as many as 10,522.1413 units. Footnotes explain that these RSUs are part of non-qualified deferred compensation plans and generally settle into ordinary shares on a 1:1 basis following the CEO’s separation from service or death, subject to specified timing rules.

Rhea-AI Summary

Tomczyk Fredric J reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson director Fredric J. Tomczyk reported receiving a grant of 925.014 restricted share units, which represent the right to receive ordinary shares of the company. The award was recorded at a price of $0.00 per share as equity compensation, not a market purchase.

The RSUs vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual General Meeting of Shareholders. Following this grant, Tomczyk’s reported direct holdings total 2,272.034 ordinary shares, including the RSUs.

Rhea-AI Summary

WILLIS TOWERS WATSON PLC director Michelle R. Swanback received an equity award in the form of 925.014 ordinary shares on 2026-05-20, recorded at a price of $0.0000 per share as a grant, not a market purchase. Following this award, her directly held ordinary shares total 2,848.034. The award is structured as restricted share units that convert into ordinary shares and will vest in full on the earlier of the one-year anniversary of the grant date or the company’s 2027 Annual General Meeting of Shareholders.

Rhea-AI Summary

REILLY PAUL C reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson plc director Paul C. Reilly reported a new equity award and updated holdings. He received 1,318.638 restricted share units, which are rights to receive ordinary shares at no cash cost. After this grant, he holds 3,146.395 ordinary shares directly and 48 shares indirectly through a revocable trust.

The restricted share units will vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual General Meeting of Shareholders, aligning his compensation with future company performance over that period.

Rhea-AI Summary

Hunt Jacqueline reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson plc director Jacqueline Hunt reported receiving a grant of 925.014 restricted share units (RSUs), each representing one ordinary share. The award was recorded at a price of $0.00 per share as part of her compensation. These RSUs will vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual General Meeting of Shareholders. Following this grant, Hunt holds 2,272.034 ordinary shares directly.

Rhea-AI Summary

Hammond Michael P. reported acquisition or exercise transactions in this Form 4 filing.

WILLIS TOWERS WATSON PLC director receives equity award through a grant of 925.014 restricted share units (RSUs) to Michael P. Hammond. These RSUs represent the right to receive ordinary shares and will vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual General Meeting of Shareholders. Following this grant, Hammond holds a total of 3,089.034 ordinary shares, including the awarded RSUs, all reported as directly owned.

Rhea-AI Summary

Chipman Stephen M. reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson plc director Stephen M. Chipman received an award of 925.014 restricted share units (RSUs). These RSUs represent the right to receive ordinary shares and carry a nominal value of $0.000304635 per share. They will vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual General Meeting of Shareholders. Following this equity grant, Chipman’s direct holdings reported in this filing increased to a total of 2,272.034 ordinary shares, reflecting routine share-based compensation rather than an open-market purchase or sale.

Rhea-AI Summary

Chima Fumbi F. reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson PLC director Fumbi F. Chima received an equity grant in the form of restricted share units. On May 20, 2026, Chima was awarded 1,417.043 ordinary-share RSUs at a price of $0.0000 per share, increasing direct holdings to 4,314.733 ordinary shares in total.

The RSUs represent the right to receive Willis Towers Watson ordinary shares with a nominal value of $0.000304635 per share. They vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual General Meeting of Shareholders, making this a routine, compensation-related award rather than a market purchase.

Rhea-AI Summary

Beale Inga K reported acquisition or exercise transactions in this Form 4 filing.

Willis Towers Watson plc director Inga K. Beale received an equity grant of 925.014 restricted share units (RSUs). The RSUs represent the right to receive the company’s ordinary shares at no purchase price and will vest in full on the earlier of the one-year anniversary of the May 20, 2026 grant date and the company’s 2027 Annual General Meeting of Shareholders. After this award, Beale holds a total of 2,848.034 ordinary shares, including the granted RSUs.

Rhea-AI Summary

Willis Towers Watson director Michael P. Hammond reported a tax-related share disposition tied to restricted share unit vesting. On the vesting and settlement of 709.655 restricted share units granted on May 15, 2025, 340.635 ordinary shares were withheld by the company at a price of $247.64 per share to cover tax obligations. After this non-market transaction, Hammond directly holds 2,164.020 ordinary shares.

Rhea-AI Summary

Willis Towers Watson PLC director Inga K. Beale reported a routine tax-withholding share disposition. On May 15, 2026, 340.635 ordinary shares were withheld by the company at $247.64 per share to cover taxes tied to vesting and settlement of 709.655 restricted share units. After this non‑market transaction, she directly holds 1,923.020 ordinary shares.

Rhea-AI Summary

Willis Towers Watson plc director Fredric J. Tomczyk reported a routine tax-related share disposition. On May 15, 340.635 ordinary shares were withheld by the company at $247.64 per share to cover taxes tied to the vesting and settlement of 709.655 restricted share units granted on May 15, 2025. After this withholding, he directly owns 1,347.020 ordinary shares, so this filing reflects compensation and tax treatment rather than an open-market trade.

Rhea-AI Summary

Willis Towers Watson director Jacqueline Hunt reported a routine tax-related share withholding. On the vesting and settlement of 709.655 restricted share units granted on May 15, 2025, the issuer withheld 340.635 Ordinary Shares at $247.64 per share to cover taxes, leaving her with 1,347.020 shares directly owned.

Rhea-AI Summary

Willis Towers Watson director Paul C. Reilly reported a tax-withholding disposition of shares tied to restricted share unit vesting. On May 15, 2026, 495.468 ordinary shares were withheld at $247.64 per share to cover taxes related to the vesting and settlement of 1,032.225 restricted share units granted on May 15, 2025. After this non-market transaction, he held 1,827.757 ordinary shares directly and 48 ordinary shares indirectly through a revocable trust.

Rhea-AI Summary

Willis Towers Watson director Stephen M. Chipman reported a routine tax-related share disposition. On May 15, 2026, 340.635 ordinary shares were withheld by the company at $247.64 per share to cover tax obligations tied to vesting restricted share units. Following this withholding, he directly holds 1,347.020 ordinary shares. The footnote explains this was connected to the vesting and settlement of 709.655 restricted share units granted on May 15, 2025, indicating a compensation and tax event rather than an open-market sale.

Rhea-AI Summary

Willis Towers Watson PLC director Michelle R. Swanback disposed of 340.635 ordinary shares through a tax-withholding arrangement tied to equity compensation. The shares were withheld by the company at a price of $247.64 per share to cover taxes on the vesting and settlement of 709.655 restricted share units granted on May 15, 2025. After this non-market transaction, she holds 1,923.020 ordinary shares directly.

Rhea-AI Summary

Willis Towers Watson plc director Fumbi F. Chima reported a routine tax-related share withholding. On May 15, 2026, 534.177 ordinary shares were withheld at $247.64 per share to cover taxes tied to the vesting and settlement of 1,112.867 restricted share units granted on May 15, 2025. After this non-market disposition, Chima holds 2,897.690 ordinary shares directly.

Rhea-AI Summary

Willis Towers Watson PLC executive Lucy Clarke, President of Risk & Broking, purchased 1,896 Ordinary Shares in an open-market trade at $263.365 per share. Following this transaction, she directly owns 22,717.453 Ordinary Shares of the company.

Rhea-AI Summary

Willis Towers Watson PLC Chief Executive Officer Carl Aaron Hess reported an open-market purchase of 2,000 Ordinary Shares on 2026-05-04 at $255.08 per share. Following this transaction, his direct ownership increased to approximately 117,425 Ordinary Shares.

Rhea-AI Summary

Willis Towers Watson PLC PAO and Controller Joseph Stephen Kurpis reported routine equity compensation activity. On April 20, 2026, he received a grant of 96.944 time-based restricted share units (RSUs), each representing one ordinary share, at a price of $0.0000 per share. These RSUs vest in three equal installments on the first, second and third anniversaries of the grant date.

On April 21, 2026, 9.582 ordinary shares were disposed of at $297.64 per share through share withholding to cover taxes related to RSU vesting, rather than an open-market sale. After these transactions, Kurpis directly holds 1,692.416 ordinary shares, including one share from previously accrued dividend equivalent rights.

Rhea-AI Summary

Willis Towers Watson Chief Human Resources Officer Kristy D. Banas reported routine equity compensation activity. On April 20, 2026, she received 770.817 time-based RSUs, representing the right to receive ordinary shares at no purchase price, vesting in three equal installments on the first, second, and third anniversaries of the grant date.

On April 21, 2026, 105.085 shares were disposed of at $297.64 per share through share withholding to cover taxes tied to RSU vesting, rather than an open-market sale. Following these transactions, she directly owns 11,298.9782 ordinary shares, which include 8 shares from previously accrued dividend equivalent rights.

Rhea-AI Summary

Willis Towers Watson Chief Operating Officer Alexis Faber reported routine equity compensation activity. She received 848.268 time-based restricted share units (RSUs), representing the right to receive ordinary shares, which will vest in three equal installments on the first, second and third anniversaries of the grant date.

In connection with the vesting and settlement of earlier RSUs, 104.014 shares were withheld by the company to cover related tax obligations at an indicated price of $297.64 per share. After these transactions, Faber holds 11,475.847 ordinary shares directly and 1 share indirectly through an immediate family member, plus 9 additional shares from previously accrued dividend equivalent rights.

Rhea-AI Summary

Willis Towers Watson executive Imran Ahmed Qureshi reported routine equity compensation activity. He received 1,053.749 time-based restricted share units (RSUs), each representing the right to receive an ordinary share. These RSUs vest in three equal annual installments on the first, second, and third anniversaries of the grant date.

The filing also shows 117.607 shares withheld by the company to cover taxes related to the vesting and settlement of earlier RSU awards, a non-market disposition. Following these transactions, Qureshi holds 2,352.656 shares directly and 9,860.871 shares indirectly through a revocable trust, reflecting a transfer of shares into that trust.

Rhea-AI Summary

Willis Towers Watson PLC Co-Head of Corporate Development Anne Pullum reported routine equity compensation activity. On April 20, she received 1,053.749 time-based restricted share units (RSUs) that will vest in equal parts on the first, second, and third anniversaries of the grant date. On April 21, 144.263 ordinary shares were withheld by the company to cover taxes related to a prior RSU vesting, at a reference price of $297.64 per share. After these transactions, she directly holds 22,363.6803 ordinary shares, including 12 shares from previously accrued dividend equivalent rights.

Rhea-AI Summary

Willis Towers Watson General Counsel Matthew Furman reported routine equity compensation activity. He received 913.917 time-based restricted share units (RSUs), representing the right to receive ordinary shares at no cost. These RSUs vest in three equal installments on the first, second and third anniversaries of the grant date.

To cover taxes related to RSU vesting and settlement from an earlier grant, 157.487 ordinary shares were withheld by the company at $297.64 per share, a non-market tax-withholding disposition. After these transactions, Furman directly holds about 35,496.8931 ordinary shares, including 8 shares from dividend equivalent rights.

Rhea-AI Summary

Willis Towers Watson plc executive Lucy Clarke reported routine equity compensation changes. On April 20, she received 1,760.995 time-based restricted share units (RSUs), each representing a right to receive an ordinary share that will vest in three equal annual installments. On April 21, 225.495 shares were withheld by the company to cover taxes related to the vesting and settlement of previously granted RSUs, leaving her with 20,821.453 ordinary shares held directly.

Rhea-AI Summary

Willis Towers Watson executive Julie Jarecke Gebauer reported equity compensation activity and related tax withholding. On April 20, 2026, she received 1,819.535 time-based restricted share units (RSUs), representing the right to receive ordinary shares that vest in three equal installments on the first, second, and third anniversaries of the grant date.

The RSU total includes 16 shares from previously accrued dividend equivalent rights that settled on April 21, 2026. To cover taxes related to vesting and settlement of RSUs granted on April 20, 2025, the issuer withheld 223.109 shares at $297.64 per share, a tax-withholding disposition rather than an open-market sale. After these transactions, she directly owned 78,022.2555 ordinary shares and also reported indirect holdings of 534 shares in each of two management trusts.